{"ticker": {"uuid": "5933789b-4be0-41a7-af8f-231642f81931", "symbol": "4768", "name": "Otsuka Corporation", "exchange": "JPX", "country": "JP", "sector": "Technology", "industry": "Information Technology Services"}, "articles": [{"title": "Otsuka stock holds steady as investors focus on healthcare pipeline", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxOLU1MZUk4Z2tROHVpTnpSRmZuWmt4YnowZ1FOa2Z1aWN6bDZ6bXAtcGNHRFdBTEc2eUE5M0dCa1FnM1hlZ3R6V05MdG9OWlZQVG1QdThiY0RONUJxSVBxbEJpRklkVDExTVNuY2V6dUpfTW04aEJLZ0NmU3VOa21tNnZMRGJPQnQyVXBqY0xFa1llRC1BUVNlSHpVcS1FdkNVb1FMQnpjOWpleTJFVjJnVld0UkRYZjA3ZzFpWGQzM0V1enlH?oc=5", "source_name": "ad-hoc-news.de", "published_at": "2026-07-09T15:28:40+00:00", "published_display": "09 Jul 2026 15:28", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Otsuka focuses on global healthcare portfolio and long-term growth strategy", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxQZEVpSjNZT19xdWNLaF9scGc1N2lUV2c4R2FlOGdWS1JrNmNHTjl0Q08tYzlLV3RzX0xTTmNCcS0yVzduQXlRSW9YbE1JRnVFRG9uSGRhNDVvbEp5R2hHYnZCZnpZOHRoZVpDS2ttd05VM1lrVVhDVVBBZU1JbU54ejFBVEJoZjBkSWpKVXMzX3Q5NmZzTFAwVEIwdTVjTm1KNnNIZ25WZVlIS19mcFFWUVhGbWNiQ2YwX3otS3VaVjV1ams?oc=5", "source_name": "ad-hoc-news.de", "published_at": "2026-07-04T14:10:25+00:00", "published_display": "04 Jul 2026 14:10", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBIT forward of OTSUKA CORPORATION \u2013 TSE:4768", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxNOHpyNDNlYzFEZENJdEZ4TWZhc2p5RDBhcUZqUGIzQ3d0WTc3Zl9TNGZERm9faGRhTFpPQ0ZEQUpmMEMwNDV3YllsdXZJZllrbTdhY2tVTkhWRlRfVUpIRFh5V3U1cTVvanNkLXRLclZkLXJobExzY0lnSnU4UlluaEh5Q0NhbG1aZExGT0NnekdhNWlIM1hIaVZYSDBFMWp0NW11d2kxcw?oc=5", "source_name": "TradingView", "published_at": "2026-07-04T12:06:40+00:00", "published_display": "04 Jul 2026 12:06", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Otsuka Corporation Just Recorded A 9.6% EPS Beat: Here's What Analysts Are Forecasting Next", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-03T07:00:00+00:00", "published_display": "03 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Otsuka buys Transcend in $1.2B deal, nabbing MDMA analog for psychiatric conditions", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxQUDdlTDhyLWQ5TnozN19NUWtDN29YbmpERFJVOUw0ZDFHZF92WDJTOElQWVpHR0N0T3lHb0YwcWdzY3JWNmgzTEJyY1NQWnFlVmU1cDhuZXJoZVRWVkcyVmR6Mld3TUhHaEFMNkxUbS1rVnJNd25WT0JWS2dYR3ZZOWkzSjZsMDBIYlVMQ2xxUHpVTFcwTm9pQ2RvSjlJVk5ydF9udmtR?oc=5", "source_name": "Fierce Biotech", "published_at": "2026-03-27T07:00:00+00:00", "published_display": "27 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Otsuka Holdings Posts Profit Surge in 2025 but Guides to Lower Earnings in 2026", "summary": "", "url": "https://news.google.com/rss/articles/CBMi8AFBVV95cUxQV1dzLW9RemhjLXhNeVpmYVp5bUVIaTctMDZ4OU80OUltTjFMbXZqWmRWSmlOYkZZUzVGQy1JdW5xdXBqMEdJMWE3dHVBbHljNDRfelZBU01WLWtzVFJxVy1MMDNrdGFOaEw0ZEtQUW0tTGRCVTdnSUxQQkhkVlY0MVdjWE0wNHY2dEF5UndWWmV0eU1hUFhrV08zMFY0X1BLQ0ZVNkxKV1ROU0E5SnBBOTRWcVFBN08zNEdOTU5xN1NoTE1TOXRCcXlLOGRzNS1CU0hnWFM1WnBnUDRGM0JTdnhSSGZsNHhibTBXVnBScEk?oc=5", "source_name": "The Globe and Mail", "published_at": "2026-02-13T08:00:00+00:00", "published_display": "13 Feb 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cantargia's 2025 was marked by Otsuka agreement and new leadership", "summary": "", "url": "https://news.google.com/rss/articles/CBMilwFBVV95cUxOYzJZZFQ1cTlJRFctMXppQ0RYdG02V1hlMU1uLWs3SlZxNVB2b1ZLRnFpdGtwSjVUaktQV3ZZTy1DQjlYTWhiMDNXTHhNMkJrQ2dKR1A4dF9Lam9wcVB1bmRQTUNiaWVpaFY2NVFRZi13RlBUZUxETkNUTmZNOGlsN0kwQlpzLVMxQjNOVm5FWVE2YnFmVFpr?oc=5", "source_name": "Biostock", "published_at": "2026-01-12T08:00:00+00:00", "published_display": "12 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Otsuka (4768) Investor Relations, Earnings Summary & Outlook", "summary": "", "url": "https://news.google.com/rss/articles/CBMiY0FVX3lxTE1EWFNOQV91NVBycjhONzIwUHN4UlVKU1FuSDdvNGZlZGZPQmY3YXVaM1ZzY1RndVYtdmtYX1pHZmFYNjlvcndKbHJHNFpEOHhVNnFTYTVmX0NFY1dFWmJwTUdUZw?oc=5", "source_name": "Quartr", "published_at": "2025-10-28T19:07:11+00:00", "published_display": "28 Oct 2025 19:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "FDA Issues CRL to Otsuka and Lundbeck for sNDA of Rexulti", "summary": "", "url": "https://news.google.com/rss/articles/CBMidkFVX3lxTE5JY2w3RnJUZGNrT2dHSWtIa0xWdEFHQWp1bUZVQmgzdTRFeVJfNlRXZkxwTThNWFVNdktoZDYxOFdRcnkwZk9rdlA3cnNjUHF2c1JqLURZZk5TMFFqODgxaGtrVXdwbUJJSEZFWlJIRWpjU1BzT1E?oc=5", "source_name": "Pharmaceutical Executive", "published_at": "2025-09-22T07:00:00+00:00", "published_display": "22 Sep 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Breaking News: Japan Approves Esperion\u2019s NEXLETOL Drug \u2014 Otsuka Takeover Speculation Builds", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxPcUstSmZGMFd2ek1USlpZRVdyd0N6Z3M1X3BGa1QtSW4yVlZKWDV6ZEh1N29CM0pfRHV6T2FoSGhjQVZuUnQ3ZmlGdVNKRVdEcDE5c253eExxLXZlcERLekJrZnVTbzh5dnZ2b1RnTmtCU3hYMjg2bVU3MTQteTUzNHVZdVhRdHBDMV9Ma3JmMWFMTlZ4ejhVYndvTWJ2a2ZBZkRLSzFsaWoyOGE3LXJlLWtyLW1ENGs3cExOSjN4Zw?oc=5", "source_name": "Moomoo", "published_at": "2025-09-19T07:00:00+00:00", "published_display": "19 Sep 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Otsuka Ready To Acquire Esperion 200%+ Upside, Jefferies Says Deal Makes Sense", "summary": "", "url": "https://news.google.com/rss/articles/CBMitwFBVV95cUxPQjhhWGxPQUFRTG5yQWFZSXZuNHpLUDV1b3huLVg1TEJOWklxcmxILTE3Vy1KaktOcjQ2YlhrS1hKZjZ5aXlndnZBd3Z5TE81UWV6UnRRaENjeEtwQU5SeGNQM1FnQ21EcDhINlpxYkc0UVpaaGZyOFF6Ql9KcjhOSDdrYTBJTUFUQmxwYndScTdKWEMzNm9PSGhXU2dvZDExN0lRQ0NmMlVDdWJvY3VieGc3VXBvZzQ?oc=5", "source_name": "Moomoo", "published_at": "2025-08-12T07:00:00+00:00", "published_display": "12 Aug 2025 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Fierce Pharma Asia\u2014Vor-RemeGen, Otsuka-Harbour autoimmune deals; Datroway's lung cancer nod", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxPLVg2eEJGTzJEVUJ2Y1lhRnc5SXdWM1htajFPVE5LTGxUNk8tQWh2N3RFaGE4X01XY3A3OUdIcVd6aDdxdnJ1MEUtMFh6UGJqaUp6bHNwb29mVDU3X0hoS3VTdHdkazdLajN4WnRhSXFLSW9MNjhWZmRRZUJ3dlRYelJvSkhjX3hOcW1mZGpZa1N2SXJWX2FseTVySzZtdWNMSkcxV3Zybw?oc=5", "source_name": "Fierce Pharma", "published_at": "2025-06-27T07:00:00+00:00", "published_display": "27 Jun 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Otsuka takes Shape to develop ocular gene therapies", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxOUjJkU0hXUjN5c3VTWTNFbDVXTHZxR3E4Skg0UFlweXlrdWg4c1hJTDhfakJTaXNpMUU3Zm9fc0toNjFZR3VVS3RpTVVNNlVldzd4Z0lxVld4a1BPOE9YWnp5YmtpR3VyMDU1SVhsRWpnY0lyOUdCTXhQQm16eHZtMlVhRlF4UXdPemxZcmVCWnFMV1FPZ3R4a3J3?oc=5", "source_name": "BioProcess International", "published_at": "2024-02-29T16:50:50+00:00", "published_display": "29 Feb 2024 16:50", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Otsuka Holdings Co., Ltd.: Shareholders Board Members Managers and Company Profile | JP3188220002", "summary": "", "url": "https://news.google.com/rss/articles/CBMiigFBVV95cUxPcElxT2puMi00My1MRG5lR05UV19vZlBvdGpBRG5WM0JTTUJiX1k1STBWMTh5THhqN1pYTV9kR2RlWnVubDJySVNQOFcyTFBlb3NQNjFkck4za2RKbzJkakNPTjhmemo3cm11eE95a25jZnh5LUQ4Sk1NUVl4WmFWVnkybWtNYTc5eEE?oc=5", "source_name": "marketscreener.com", "published_at": "2020-08-18T21:32:33+00:00", "published_display": "18 Aug 2020 21:32", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Otsuka stock holds steady as investors focus on healthcare pipeline", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxOLU1MZUk4Z2tROHVpTnpSRmZuWmt4YnowZ1FOa2Z1aWN6bDZ6bXAtcGNHRFdBTEc2eUE5M0dCa1FnM1hlZ3R6V05MdG9OWlZQVG1QdThiY0RONUJxSVBxbEJpRklkVDExTVNuY2V6dUpfTW04aEJLZ0NmU3VOa21tNnZMRGJPQnQyVXBqY0xFa1llRC1BUVNlSHpVcS1FdkNVb1FMQnpjOWpleTJFVjJnVld0UkRYZjA3ZzFpWGQzM0V1enlH?oc=5", "source_name": "ad-hoc-news.de", "published_at": "2026-07-09T15:28:40+00:00", "published_display": "09 Jul 2026 15:28", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Otsuka focuses on global healthcare portfolio and long-term growth strategy", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxQZEVpSjNZT19xdWNLaF9scGc1N2lUV2c4R2FlOGdWS1JrNmNHTjl0Q08tYzlLV3RzX0xTTmNCcS0yVzduQXlRSW9YbE1JRnVFRG9uSGRhNDVvbEp5R2hHYnZCZnpZOHRoZVpDS2ttd05VM1lrVVhDVVBBZU1JbU54ejFBVEJoZjBkSWpKVXMzX3Q5NmZzTFAwVEIwdTVjTm1KNnNIZ25WZVlIS19mcFFWUVhGbWNiQ2YwX3otS3VaVjV1ams?oc=5", "source_name": "ad-hoc-news.de", "published_at": "2026-07-04T14:10:25+00:00", "published_display": "04 Jul 2026 14:10", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBIT forward of OTSUKA CORPORATION \u2013 TSE:4768", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxNOHpyNDNlYzFEZENJdEZ4TWZhc2p5RDBhcUZqUGIzQ3d0WTc3Zl9TNGZERm9faGRhTFpPQ0ZEQUpmMEMwNDV3YllsdXZJZllrbTdhY2tVTkhWRlRfVUpIRFh5V3U1cTVvanNkLXRLclZkLXJobExzY0lnSnU4UlluaEh5Q0NhbG1aZExGT0NnekdhNWlIM1hIaVZYSDBFMWp0NW11d2kxcw?oc=5", "source_name": "TradingView", "published_at": "2026-07-04T12:06:40+00:00", "published_display": "04 Jul 2026 12:06", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Otsuka Corporation Just Recorded A 9.6% EPS Beat: Here's What Analysts Are Forecasting Next", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-03T07:00:00+00:00", "published_display": "03 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Otsuka buys Transcend in $1.2B deal, nabbing MDMA analog for psychiatric conditions", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxQUDdlTDhyLWQ5TnozN19NUWtDN29YbmpERFJVOUw0ZDFHZF92WDJTOElQWVpHR0N0T3lHb0YwcWdzY3JWNmgzTEJyY1NQWnFlVmU1cDhuZXJoZVRWVkcyVmR6Mld3TUhHaEFMNkxUbS1rVnJNd25WT0JWS2dYR3ZZOWkzSjZsMDBIYlVMQ2xxUHpVTFcwTm9pQ2RvSjlJVk5ydF9udmtR?oc=5", "source_name": "Fierce Biotech", "published_at": "2026-03-27T07:00:00+00:00", "published_display": "27 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Otsuka Holdings Posts Profit Surge in 2025 but Guides to Lower Earnings in 2026", "summary": "", "url": "https://news.google.com/rss/articles/CBMi8AFBVV95cUxQV1dzLW9RemhjLXhNeVpmYVp5bUVIaTctMDZ4OU80OUltTjFMbXZqWmRWSmlOYkZZUzVGQy1JdW5xdXBqMEdJMWE3dHVBbHljNDRfelZBU01WLWtzVFJxVy1MMDNrdGFOaEw0ZEtQUW0tTGRCVTdnSUxQQkhkVlY0MVdjWE0wNHY2dEF5UndWWmV0eU1hUFhrV08zMFY0X1BLQ0ZVNkxKV1ROU0E5SnBBOTRWcVFBN08zNEdOTU5xN1NoTE1TOXRCcXlLOGRzNS1CU0hnWFM1WnBnUDRGM0JTdnhSSGZsNHhibTBXVnBScEk?oc=5", "source_name": "The Globe and Mail", "published_at": "2026-02-13T08:00:00+00:00", "published_display": "13 Feb 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cantargia's 2025 was marked by Otsuka agreement and new leadership", "summary": "", "url": "https://news.google.com/rss/articles/CBMilwFBVV95cUxOYzJZZFQ1cTlJRFctMXppQ0RYdG02V1hlMU1uLWs3SlZxNVB2b1ZLRnFpdGtwSjVUaktQV3ZZTy1DQjlYTWhiMDNXTHhNMkJrQ2dKR1A4dF9Lam9wcVB1bmRQTUNiaWVpaFY2NVFRZi13RlBUZUxETkNUTmZNOGlsN0kwQlpzLVMxQjNOVm5FWVE2YnFmVFpr?oc=5", "source_name": "Biostock", "published_at": "2026-01-12T08:00:00+00:00", "published_display": "12 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Otsuka (4768) Investor Relations, Earnings Summary & Outlook", "summary": "", "url": "https://news.google.com/rss/articles/CBMiY0FVX3lxTE1EWFNOQV91NVBycjhONzIwUHN4UlVKU1FuSDdvNGZlZGZPQmY3YXVaM1ZzY1RndVYtdmtYX1pHZmFYNjlvcndKbHJHNFpEOHhVNnFTYTVmX0NFY1dFWmJwTUdUZw?oc=5", "source_name": "Quartr", "published_at": "2025-10-28T19:07:11+00:00", "published_display": "28 Oct 2025 19:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "FDA Issues CRL to Otsuka and Lundbeck for sNDA of Rexulti", "summary": "", "url": "https://news.google.com/rss/articles/CBMidkFVX3lxTE5JY2w3RnJUZGNrT2dHSWtIa0xWdEFHQWp1bUZVQmgzdTRFeVJfNlRXZkxwTThNWFVNdktoZDYxOFdRcnkwZk9rdlA3cnNjUHF2c1JqLURZZk5TMFFqODgxaGtrVXdwbUJJSEZFWlJIRWpjU1BzT1E?oc=5", "source_name": "Pharmaceutical Executive", "published_at": "2025-09-22T07:00:00+00:00", "published_display": "22 Sep 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Breaking News: Japan Approves Esperion\u2019s NEXLETOL Drug \u2014 Otsuka Takeover Speculation Builds", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxPcUstSmZGMFd2ek1USlpZRVdyd0N6Z3M1X3BGa1QtSW4yVlZKWDV6ZEh1N29CM0pfRHV6T2FoSGhjQVZuUnQ3ZmlGdVNKRVdEcDE5c253eExxLXZlcERLekJrZnVTbzh5dnZ2b1RnTmtCU3hYMjg2bVU3MTQteTUzNHVZdVhRdHBDMV9Ma3JmMWFMTlZ4ejhVYndvTWJ2a2ZBZkRLSzFsaWoyOGE3LXJlLWtyLW1ENGs3cExOSjN4Zw?oc=5", "source_name": "Moomoo", "published_at": "2025-09-19T07:00:00+00:00", "published_display": "19 Sep 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Otsuka Ready To Acquire Esperion 200%+ Upside, Jefferies Says Deal Makes Sense", "summary": "", "url": "https://news.google.com/rss/articles/CBMitwFBVV95cUxPQjhhWGxPQUFRTG5yQWFZSXZuNHpLUDV1b3huLVg1TEJOWklxcmxILTE3Vy1KaktOcjQ2YlhrS1hKZjZ5aXlndnZBd3Z5TE81UWV6UnRRaENjeEtwQU5SeGNQM1FnQ21EcDhINlpxYkc0UVpaaGZyOFF6Ql9KcjhOSDdrYTBJTUFUQmxwYndScTdKWEMzNm9PSGhXU2dvZDExN0lRQ0NmMlVDdWJvY3VieGc3VXBvZzQ?oc=5", "source_name": "Moomoo", "published_at": "2025-08-12T07:00:00+00:00", "published_display": "12 Aug 2025 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Fierce Pharma Asia\u2014Vor-RemeGen, Otsuka-Harbour autoimmune deals; Datroway's lung cancer nod", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxPLVg2eEJGTzJEVUJ2Y1lhRnc5SXdWM1htajFPVE5LTGxUNk8tQWh2N3RFaGE4X01XY3A3OUdIcVd6aDdxdnJ1MEUtMFh6UGJqaUp6bHNwb29mVDU3X0hoS3VTdHdkazdLajN4WnRhSXFLSW9MNjhWZmRRZUJ3dlRYelJvSkhjX3hOcW1mZGpZa1N2SXJWX2FseTVySzZtdWNMSkcxV3Zybw?oc=5", "source_name": "Fierce Pharma", "published_at": "2025-06-27T07:00:00+00:00", "published_display": "27 Jun 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Otsuka takes Shape to develop ocular gene therapies", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxOUjJkU0hXUjN5c3VTWTNFbDVXTHZxR3E4Skg0UFlweXlrdWg4c1hJTDhfakJTaXNpMUU3Zm9fc0toNjFZR3VVS3RpTVVNNlVldzd4Z0lxVld4a1BPOE9YWnp5YmtpR3VyMDU1SVhsRWpnY0lyOUdCTXhQQm16eHZtMlVhRlF4UXdPemxZcmVCWnFMV1FPZ3R4a3J3?oc=5", "source_name": "BioProcess International", "published_at": "2024-02-29T16:50:50+00:00", "published_display": "29 Feb 2024 16:50", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Otsuka Holdings Co., Ltd.: Shareholders Board Members Managers and Company Profile | JP3188220002", "summary": "", "url": "https://news.google.com/rss/articles/CBMiigFBVV95cUxPcElxT2puMi00My1MRG5lR05UV19vZlBvdGpBRG5WM0JTTUJiX1k1STBWMTh5THhqN1pYTV9kR2RlWnVubDJySVNQOFcyTFBlb3NQNjFkck4za2RKbzJkakNPTjhmemo3cm11eE95a25jZnh5LUQ4Sk1NUVl4WmFWVnkybWtNYTc5eEE?oc=5", "source_name": "marketscreener.com", "published_at": "2020-08-18T21:32:33+00:00", "published_display": "18 Aug 2020 21:32", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 70, "total_relevant": 14, "sentiment_summary": {"positive": 4, "negative": 0, "neutral": 10, "score": 54, "total": 14, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 82, "events": [{"event": "general", "label": "Market update", "weight": 4.95, "count": 9}, {"event": "earnings", "label": "Earnings", "weight": 1.65, "count": 3}, {"event": "deals", "label": "Deals and strategy", "weight": 1.1, "count": 2}], "positive_events": 4, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 2893.5, "latest_week": "2026-07-10", "one_week_move": 1.4, "four_week_move": 3.4, "twelve_week_move": -5.1, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -0.90221, "market_dynamics_buy_signal": false, "relative_strength": -26.931134, "fair_value_gap": -4.5, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "undecided", "expectation_probability": 54.4338, "reaction_label": "Price digesting", "reaction_tone": "neutral", "market_sentence": "+1.4% over one week, +3.4% over four weeks, trend inactive, and near fair-value range."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 64, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "ad-hoc-news.de", "count": 2}, {"label": "Moomoo", "count": 2}, {"label": "TradingView", "count": 1}, {"label": "simplywall.st", "count": 1}, {"label": "Fierce Biotech", "count": 1}, {"label": "The Globe and Mail", "count": 1}, {"label": "Biostock", "count": 1}, {"label": "Quartr", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 14}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 9}, {"label": "Earnings", "count": 3}, {"label": "Deals and strategy", "count": 2}]}, "insights": [{"label": "Weighted tone", "value": "54/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "82/100 classification confidence."}, {"label": "Company focus", "value": "14", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "+1.4% over one week, +3.4% over four weeks, trend inactive, and near fair-value range."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Otsuka stock holds steady as investors focus on healthcare pipeline"}], "updated_at": "2026-07-17T10:27:00.069707+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}